The global neuroblastoma treatment market size was valued at USD 442 billion in 2021 and is poised to grow at a significant CAGR of 3.6% during the forecast period 2022-28. One of the most frequent types of cancer in youngsters is neuroblastoma. The cancer is caused by embryonal malignancy in the sympathetic nervous system, which arises mostly from neuroblasts. Cancer of the nerve tissues of...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian